In This Episode
Oxford University’s vaccine could be up to 90 per cent effective, data from phase III trials shows today. With the UK government ordering 100 million doses of the jab, could it mean a return to normality is on the horizon? Katy Balls speaks to Fraser Nelson and James Forsyth.
Comments
Black Friday sale: Get 10 weeks for just $1
Unlimited access to the The Spectator, online and via the app
SUBSCRIBE NOW Just $1 for 10 weeksAlready a subscriber? Log in